Observational studyMedicina (Kaunas, Lithuania)2018

Daily Cisplatin and Weekly Docetaxel versus Weekly Cisplatin Intra-Arterial Chemoradiotherapy for Late T2-3 Tongue Cancer: A Pilot and Feasibility Trial.

Yuichiro Hayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.